Annual reports are in PDF format for the years 2002 till 2016 and can be downloaded below. The IFRS reports are only available in Norwegian.
Annual report 2016
Annual report 2015 IFRS (Norwegian)
Annual report 2014 IFRS (Norwegian)
- Annual Report 2014 (page turn function)
Annual report 2013 IFRS (Norwegian)
- Annual report 2013 (page turn function)
Annual report 2012 IFRS (Norwegian)
Annual report 2010 IFRS (Norwegian)
Quarterly reports are available from the 2nd quarter, 2005. All downloads are in PDF format.
Presentations and webcasts
- Biotec Pharmacon: Q4 2016 Presentation
- Biotec Pharmacon: Q3 2016 Presentation
- Presentation of the second quarter 2016 report
- Biotec Pharmacon presents at Anglonordic Life Science Conference
- Biotec Pharmacon ASA presents at Sparebank1 Nord-Norge Markets Investorseminar
- Pareto Securities Health Care Seminar 2015
- Presentation from Carnegie
- Presentation of the second quarter 2015 report
- Presentation of Q2 2015 results
- Presentation of the first quarter 2015 report
The interim reports of Biotec Pharmacon are followed by a presentation. Usually these presentations are made available as webcasts. Each webcast is available for at least 12 months.
- Presentation Q2-2016, August 17, 2016
- Presentation Q1-2016, April 19, 2016
- Presentation Q4-2015 and CMD, February 11, 2016
- Presentation Q3-2015, November 3, 2015
- Presentation Q2-2015, August 13, 2015
- Presentation Q1-2015, May 5, 2015
- Presentation Q4-2014, February 17, 2015
- Presentation Q3-2014, November 5, 2014
- Presentation Q2-2014, August 13, 2014
- Presentation Q1-2014, April 30, 2014
- Presentation Q4-2013, February 14, 2014
- Presentation Q3-2013, November 1, 2013
- Presentation Q2-2013, August 9, 2013
- Presentation Q1-2013, May 7, 2013
ProspectusIf you are a U.S. Person or reside in the United States, Canada, Australia or Japan or Any Other Jurisdiction in which the distribution would be unlawful, you may not view the materials linked herein.
The information contained on the following pages of our web site is restricted and may not be viewed by U.S. Persons (as defined in SEC Regulation S) or any person located in the United States. This information relates to an offering of securities by Biotec Pharmacon ASA (the “Company”) which is not a public offering in the United States and therefore applicable U.S. law strictly limits access to this information.
The material in the following pages is strictly confidential and is being furnished by the Company only to persons who are entitled to participate in this offering of securities. The delivery of the Offering Circular and the attached subscription materials, in whole or in part, or any disclosure of its contents or use of any information herein for any purpose other than considering an investment in the shares of the Company is prohibited. The following materials may not, in whole or in part, be reproduced, copied or forwarded to any U.S. person or any person located in the United States. By clicking either Prospectus below you are expressly confirming to the Company, and its advisors, that you are not a U.S. person and that you are not accessing this web-site from the United States. If you cannot make these representations you are required by applicable law to EXIT this page.